Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01621477
Title T-Cell Replete Haploidentical Donor Hematopoietic Stem Cell Plus Natural Killer (NK) Cell Transplantation in Patients With Hematologic Malignancies Relapsed or Refractory Despite Previous Allogeneic Transplant
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors St. Jude Children's Research Hospital
Indications

non-Hodgkin lymphoma

acute myeloid leukemia

bone marrow cancer

acute lymphoblastic leukemia

Hodgkin's lymphoma

chronic myeloid leukemia

juvenile myelomonocytic leukemia

Therapies

Plerixafor

Tacrolimus

Mycophenolate mofetil

anti-thymocyte globulin + Busulfan + Clofarabine

Cyclophosphamide + Cytarabine

Age Groups: child | adult
Covered Countries USA


No variant requirements are available.